As per the journal JAMA Network Open’s recently published study, the things in marijuana derivatives can differ a lot from distributor claims. That is especially important when tetrahydrocannabinol is in medical marijuana items labeled as cannabidiol-only goods. This pertains to CBD label accuracy as much as it does to THC’s labeling precision.
With more states legalizing marijuana’s sales, the demand for it has gone up. Anyhow, there is not much consistency in marijuana product labeling or regulation, unlike the stringent regulation of pharmaceuticals. Consequently, CBD labels and packaging tend not to correctly inform customers of the marijuana product’s content.
The mind-altering form of THC in marijuana is delta-9-tetrahydrocannabinol. Marijuana derivatives with that THC are prohibited at a federal level, but states sometimes pass laws that legalize those goods. That has caused an assortment of laws with varied effects on ensuring that people get the product they expect. The FDA still does not regulate the CBD market properly.
In the said study, researchers looked at the urine samples of almost 100 patients to know how medical marijuana affects their depression, insomnia, anxiety or pain. The study’s purpose was to know whether the goods deliver the components that patients expected to get.
There was no cannabidiol in around one-third of those urine samples of people who used marijuana derivatives with more CBD or equal amounts of THC and cannabidiol. THC was found in around 80% of the samples, including those of patients who felt they were ingesting cannabidiol alone.
People who purchase the goods assume that those are devoid of THC, but they actually contain that psychoactive substance considerably, said the study’s lead author Jodi Gilman. For your information, Gilman is also an investigator at the Massachusetts General Hospital’s Center for Addiction Medicine. A patient reportedly took an item she felt only had cannabidiol, and experienced intoxication, disorientation and scaredness while driving home.
The exact amount of cannabis consumed is also important in this regard. The urine samples of around 20% of patients who stated that they vaped medical marijuana, lacked detectable quantities of CBD or THC metabolites. That indicates that some CBD vaping tools are perhaps not heating cannabis goods enough for users to breathe in the active components.
There are still many questions regarding the product and its effects, Gilman said. Patients require more details regarding the product content and the possible effects of the item.